Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina

被引:19
作者
Fiscus, SA
Adimora, AA
Funk, ML
Schoenbach, VJ
Tristram, D
Lim, W
McKinney, R
Rupar, D
Woods, C
Wilfert, C
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[5] E Carolina Univ, Dept Pediat, Greenville, NC USA
[6] Duke Univ, Dept Pediat, Durham, NC 27706 USA
[7] Carolinas Med Ctr, Dept Pediat, Charlotte, NC USA
[8] Wake Forest Univ, Dept Pediat, Winston Salem, NC 27109 USA
关键词
perinatal human immunodeficiency virus transmission; elective cesarean delivery; antiretroviral therapy; North Carolina;
D O I
10.1097/00006454-200207000-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Mother-to-child transmission of HIV has decreased in industrialized countries because of widespread use of antiretroviral therapy (ART) by HIV-infected pregnant women and perhaps to increased use of elective cesarean section. We evaluated changes in the use of ART and mode of delivery among HIV-positive pregnant women in North Carolina. Methods. We reviewed the medical records of HIV-exposed infants born in North Carolina between January 1, 1998, and December 31, 1999, who were tested for HIV DNA. These results were compared with data collected on HIV-exposed infants born from 1993 through 1997. Results. The use of combination ART increased from 1.5% in 1996 to 73% in 1999. The most common ART was zidovudine/lamivudine (39%) followed by zidovudine-lamivudine-nelfinavir (34%), although 34 combinations were used. Elective cesarean sections in the state increased significantly from 16.5% in the first half of 1998 to 49.4% in the second half of 1999. Overall transmission rates declined from 24.5% in 1993 to an average of 10.6% in 1994 to 1996 (41 of 385) and to 3.5% in 1997 to 1999 (15 of 428). Conclusions. Increased use of combination ART and elective cesarean section was accompanied by consistently low rates of perinatal transmission. However, because perinatal transmission rates were also low among women who used combination therapy and had vaginal deliveries, it is difficult to determine how much additional benefit cesarean section affords. Most HIV transmission occurred among women who lacked prenatal care and did not receive or adhere to ART.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 40 条
[1]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[2]  
Byers RH, 1998, STAT MED, V17, P169, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt
[3]  
169::AID-SIM759&gt
[4]  
3.0.CO
[5]  
2-8
[6]   Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women [J].
Chen, KT ;
Sell, RL ;
Tuomala, RE .
OBSTETRICS AND GYNECOLOGY, 2001, 97 (02) :161-168
[7]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[8]   After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants [J].
Cooper, ER ;
Nugent, RP ;
Diaz, C ;
Pitt, J ;
Hanson, C ;
Kalish, LA ;
Mendez, H ;
Zorrilla, C ;
Hershow, R ;
Moye, J ;
Smeriglio, V ;
Fowler, MG ;
Rich, K ;
Turpin, D ;
PachecoAcosta, E ;
Tuomala, R ;
Mesthene, D ;
Fox, H ;
Higgins, A ;
Landesman, S ;
Moroso, G ;
Willoughby, A ;
Sheon, A ;
McKinlay, S ;
Sherrieb, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1207-1211
[9]  
DOMINGUEZ K, 2001, 8 C RETR OPP INF CHI
[10]  
FISCUS S, 2000, 13 INT AIDS C DURB S